Baker Heart and Diabetes Institute
Baker Heart and Diabetes Institute
Melbourne, Victoria, Australia17 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 2 | 2026-10-07 | NCT07668388 | |
| PERCEIVE-Outreach: A Scalable, Risk-Based Model for Managing Persistent Cardiovascular Impact in Long COVID | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, long COVID-19, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not applicable | 2026-10-06 | NCT07661862 | |
| A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 3 | 2026-09-30 | NCT07754461 | |
| Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Enrolling by invitation | Not applicable | 2026-09-24 | NCT07197788 | |
| REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels | cardiovascular disorder | Active, not recruiting | Phase 3 | 2026-08-31 | NCT05669755 | |
| Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Active, not recruiting | Not applicable | 2026-08-05 | NCT06267391 | |
| The STOP-MED CTRCD Trial | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer, cardiovascular disorder, heart disorder, heart failure, injury, neoplasm, radiation injury | Recruiting | Phase 4 | 2026-07-07 | NCT06183437 | |
| The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. | Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, autoimmune disease, cardiovascular disorder, diabetes mellitus, diabetic kidney disease, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, glucose metabolism disease, immune system disorder, kidney disorder, metabolic disease, retinal disorder, type 1 diabetes mellitus, urinary system disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-01-20 | NCT01320345 | |
| Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance | Aneurysm, cardiovascular disorder, vascular disorder | Recruiting | Not applicable | 2025-12-16 | NCT06894875 | |
| Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Not stated | 2025-12-04 | NCT05366153 | |
| Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin | Acid-Base Imbalance, Ketosis, Nutritional and Metabolic Diseases, acidosis disorder, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Not yet recruiting | Phase 2 | 2025-11-06 | NCT07225465 | |
| Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE) | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2025-10-03 | NCT04983823 | |
| Exercise to Improve Neurovascular Function in Breast Cancer Survivors | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Not applicable | 2025-10-02 | NCT06925529 | |
| Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM) | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2025-05-31 | NCT04962711 | |
| Echo Acquisition Despite Geographic Separation by Replication of Human Movements (EAGER) | Echocardiography | Not yet recruiting | Not applicable | 2024-12-19 | NCT06742905 | |
| Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy | Diabetes Complications, Diabetic Cardiomyopathies, Nutritional and Metabolic Diseases, cardiomyopathy, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, metabolic disease, type 2 diabetes mellitus | Active, not recruiting | Phase 3 | 2022-12-08 | NCT04083339 | |
| Prospective Athlete's Heart Study | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiomyopathy, cardiovascular disorder, heart disorder | Recruiting | Not stated | 2021-12-20 | NCT05164328 |